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Abstract
Background: The relationship between the apolipoprotein E (APOE) polymorphism and intracranial aneurysms has
previously only been studied in Russia and Japan but not in Chinese populations. The purpose of this study was to
investigate the association between APOE polymorphism and the risk of intracranial aneurysms in a Chinese
population.
Methods: The study population consisted of 150 intracranial aneurysms patients and 150 matched control subjects.
The APOE gene polymorphism was analyzed using polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP).
Results: Patients with intracranial aneurysms had a significantly higher frequency of APOE E2/E2 genotype [odds
ratio (OR) =9.51, 95 % confidence interval (CI) = 1.19, 76.04; P = 0.03] and APOE E2/E3 genotype (OR = 1.87, 95 %
CI = 1.03, 3.40; P = 0.04) than healthy controls. The APOE E4/E4 genotype frequencies (OR = 0.09, 95 % CI = 0.01,
0.74; P = 0.03) in the intracranial aneurysms group were significantly lower than those in the controls group. When
stratified by the site, shape, size and the Fisher Grade of intracranial aneurysms, no statistically significant result
was observed.
Conclusion: Our study suggested that APOE polymorphism might be associated with intracranial aneurysms in
Chinese population. Additional studies are needed to confirm this finding.
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Background
Intracranial aneurysm is a fairly common condition that
is often asymptomatic until the time of rupture. A sys-
tematic review of studies involving more than 56,000 pa-
tients found that unruptured intracranial aneurysms
occur in 3.6 to 6 % of the general population [1]. Rup-
ture of intracranial aneurysms accounts for more than
90 % of subarachnoid hemorrhage cases [2]. Intracranial
aneurysms may result from diseases acquired during life,
or from genetic conditions. Lifestyle diseases including
hypertension, smoking, excess alcohol consumption, and
obesity are associated with the development of aneurysms
[3–5]. Genome-wide association studies (GWAS) of
intracranial aneurysm in European and Japanese case-
control cohorts have identified several new risk loci [6–9].
Apolipoprotein E (apoE), a 299-amino acid, arginine-
rich glycoprotein, is an integral surface component of
chylomicrons, very-low-density lipoproteins, and some
subclasses of high-density lipoproteins [10, 11]. The
APOE gene is polymorphic, consisting of 3 common al-
leles (E2, E3, and E4) and 6 different genotypes (E2/E2,
E2/E3, E2/E4, E3/E3, E3/E4 and E4/E4) [11]. APOE gene
polymorphisms seem to have some impact among pa-
tients with cardiovascular disease [12].
The relationship between the APOE polymorphism and
intracranial aneurysms has previously only been studied in
Russia and Japan but not in Chinese populations [13, 14].
The purpose of this study was to investigate the associ-
ation between APOE polymorphisms and the risk of intra-
cranial aneurysms in a Chinese population.
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A hospital-based case-control study was conducted in
150 patients with intracranial aneurysms and 150 age-
and gender-matched healthy controls during the years
2009 to 2014 in the Department of Neurosurgery, The
First Affiliated Hospital of Xi’an Jiao Tong University,
China. Peripheral blood specimens and demographic,
medical, and family histories were obtained from se-
quentially ascertained, unrelated patients. Intracranial
aneurysms in the cases were confirmed by magnetic res-
onance imaging (MRI) or computed tomography angiog-
raphy (CTA) or cerebral angiography. Most intracranial
aneurysms cases have no symptoms and may only be
discovered during tests for another, usually unrelated,
condition. The healthy control subjects were collected
from the same geographic region and were attending a
clinic for routine examination in the Department of
Neurosurgery, The First Affiliated Hospital of Xi’an Jiao
Tong University. The control subjects met the following
criteria: (1) confirmation of the absence of intracranial
aneurysms by digital subtraction angiography, magnetic
resonance angiography, or 3-dimensional computed tom-
ography angiography; (2) a similar age and sex distribution;
(3) no medical history of any vascular disease, including
intracranial aneurysms or subarachnoid hemorrhage; (4)
no family history of intracranial aneurysms or subarach-
noid hemorrhage in first-degree relatives; and (5) the same
population as the cases. The Ethical Committee of the First
Affiliated Hospital of Xi’an Jiao Tong University approved
the study protocols, and all participants gave written in-
formed consent according to the Declaration of Helsinki.
DNA extraction and genotyping
The commercially available Qiagen kit (QIAGEN Inc.,
Valencia, CA, USA) was used to extract DNA from periph-
eral blood leukocytes. Polymerase chain reaction restriction
fragment length polymorphism (PCR-RFLP) assay was ap-
plied to assess the APOE gene polymorphisms. Based on
the GenBank reference sequence, the PCR primers were as
follows: sense, ACAGAATTCGCCCCGGCCTGGTACAC;
antisense, TAAGCTTGGCACGGCTGTCCAAGGA. The
amplified PCR products were then digested with 2U of
Hha I (New England BioLabs, Missisauga, ON, Canada) at
37 °C for 3 h. The resulting DNA fragments were electro-
phoresed on 3.5 % agarose gel and visualized under UV
light after ethidum staining.
Statistical analysis
The Statistical Analyses System (SAS) package (version
8.01; SAS Institute, Cary, NC) was used for statistical
analysis. Differences between continuous variables were
assessed by Student’s t test, while those between categor-
ical variables were evaluated using Pearson x2 test. The
existence of differences in genotypic frequencies between
groups was assessed by means of Pearson x2 test and
calculating the odds ratio (OR) with the 95 % confidence
intervals (CI). A P-value was considered significant at a
level of < 0.05. A chi-square test was used to confirm
that the APOE genotype frequencies were in Hardy-
Weinberg equilibrium.
Results
The characteristics of patients with intracranial aneu-
rysms and controls were shown in Table 1. As to clinical
characteristics, there was no statistical significant differ-
ence in gender, age or the prevalence of risk factors in-
cluding hypertension, smoking and drinking between the
patient with intracranial aneurysms and control groups,
as shown in Table 1. The site of aneurysm was as fol-
lows: anterior cerebral artery, 67 (44.7 %); internal ca-
rotid artery, 53 (35.3 %); and middle cerebral artery, 30
(20.0 %). The shape of aneurysm was as follows: saccular,
119 (79.3 %); fusiform, 24 (16.0 %); dissecting, 7 (4.7 %).
Table 1 Characteristics of patients with intracranial aneurysms
and controls
Aneurysms Controls P
Total No. 150 150
Gender (Male/Female) 67/83 65/85 0.82
Age (years) 46.7 ± 10.9 47.2 ± 11.2 0.70
Hypertension (Yes/No) 53/97 49/101 0.63
Smoking (Yes/No) 37/113 35/115 0.79
Drinking (Yes/No) 31/119 30/120 0.89








Size of aneurysm (%)
Small (<15 mm) 106(70.7) /
Larger (15-25 mm) 37(24.7) /
Giant (>25 mm) 7(4. 6) /
The Fisher Grade
Grade 1 14(9.4) /
Grade 2 74(49.3) /
Grade 3 44(29.3) /
Grade 4 18(12.0) /
ACA, anterior cerebral artery; ICA, internal carotid artery; MCA, middle cerebral
artery. Smoking was defined as non-smoker (smoked less than 100 cigarettes in
lifetime) and smoker. Drinking was defined as non-drinker and drinker (consumed
more than one cup, 200 mL, per day)
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The size of aneurysm was as follows: small (<15 mm),
106 (70.7 %); larger (15–25 mm), 37 (24.7 %); giant
(>25 mm), 7 (4.6 %). The Fisher Grade was as follows:
Grade 1, 14 (9.4 %); Grade 2, 74 (49.3 %); Grade 3, 44
(29.3 %); Grade 4, 18 (12.0 %) (Table 1).
Patients with intracranial aneurysms had a significantly
higher frequency of APOE E2/E2 genotype (OR = 9.51,
95 % CI = 1.19, 76.04; P = 0.03) and APOE E2/E3 geno-
type (OR = 1.87, 95 % CI = 1.03, 3.40; P = 0.04) than
healthy controls (Table 2). The APOE E4/E4 genotype
frequencies (OR = 0.09, 95 % CI = 0.01, 0.74; P = 0.03) in
the intracranial aneurysms group were significantly
lower than those in the controls group (Table 2). When
stratified by the site, shape, size and the Fisher Grade of
intracranial aneurysms, no statistically significant result
was observed (Table 3).
Discussion
Although lot of studies have been conducted to examine
the association of genetic polymorphism and intracranial
aneurysms, the relationship between the APOE poly-
morphism and intracranial aneurysms has previously
only been studied in Russia and Japan but not in Chin-
ese populations [13, 14]. Evidence from a case-control
study suggested that the collagen type I alpha2 gene
polymorphism was associated with intracranial aneu-
rysms in a subset of the German population [15]. Au-
thors of a case-control study suggested that the IL-12A
and IL-12B independently and jointly was involved in
the susceptibility to intracranial aneurysms in a Chinese
population [16]. Evidence from a meta-analysis included
six case-control studies, which included 1188 intracra-
nial aneurysms cases and 4099 controls, suggested that
IL-6 promoter polymorphisms (-174G/C and -572G/C)
were associated with intracranial aneurysms [17]. Au-
thors of a case-control study in a Chinese population
suggested that the miR-34b/c rs4938723CC and TP53
Arg72-Pro polymorphisms may be involved in the sus-
ceptibility to intracranial aneurysms [18]. Evidence from
a case-control study indicated that the elastin gene poly-
morphism might be associated with the formation and
the rupture of intracranial aneurysms [19]. Evidence from
a genetic meta-analysis of 8 genes and 13 polymorphisms
in approximately 20,000 individuals showed that there was
a likely genetic basis to sporadic intracranial aneurysms.
However, the evidence base was small when compared
against other complex disorders [20]. Authors of a case-
control study suggested that the NFKB1 -94ins/del ATTG
polymorphism might contribute to the risk of intracranial
aneurysms [21]. Polymorphisms within the kallikrein gene
cluster are associated with intracranial aneurysms suggest-
ing that the kallikreins are important candidate genes for
intracranial aneurysms [22]. Evidence from a case-control
study suggested that the angiotensin-converting enzyme
DD genotype might be a protective factor for intracranial
aneurysms in a Chinese population [23]. Evidence from a
meta-analysis of case-control studies also suggested that
there was a close relationship between angiotensin-
converting enzyme I/D polymorphism and intracranial an-
eurysms risk [24]. The study by Pannu et al. and Peters et
al. supported a role for MMP-9 in the pathogenesis of
intracranial aneurysms [25, 26]. Genome-wide association
study for intracranial aneurysm in the Japanese population
identified three candidate susceptible loci and a functional
genetic variant at EDNRA [8].
The APOE gene polymorphisms were also associated
with many other diseases. Authors of a case-control
study showed that the APOE epsilon polymorphism has
the expected impact on the plasma lipid profile and the
rs4420638 G allele may counterbalance the deleterious
effect of the E4 allele on low-density lipoproteins (LDL)-
cholesterol levels in an Algerian population [11]. Evi-
dence from a meta-analysis of 29 studies suggested that
APOE gene polymorphisms was associated with the risk
of vascular dementia [27]. Evidence from a meta-analysis
of 28 case-control studies provided evidence for an asso-
ciation between the APOE E4 allele and frontotemporal
lobar degeneration [28]. Authors of a case-control study
found that APOE gene polymorphism was associated
with maximal oxygen uptake levels after exercise train-
ing in Chinese young adult [29]. Evidence from a meta-
analysis of experimental and human studies suggested
an association between APOE gene expression and its
gene polymorphism with nephrotic syndrome suscepti-
bility [30]. Evidence from a meta-analysis of 45 studies
found that APOE gene polymorphisms were associated
with essential hypertension [31]. Authors of a hospital-
based case-control study suggested that APOE E3/E4
genotype was associated with a higher lower extremity
deep venous thrombosis risk [32]. Evidence from a
meta-analysis of seven studies suggested that the APOE
polymorphisms were associated with the risk of psoria-
sis, especially E2 and E3 alleles [33]. A meta-analysis of
seven studies suggested an association between APOE
E4 mutation and increased risk of recurrent pregnancy
loss [34]. Evidence from a meta-analysis of 6977 subjects
provides evidence that APOE E2 mutation is associated
Table 2 Genotype frequencies of APOE gene polymorphisms
among intracranial aneurysms cases and controls
Genotype Aneurysms Controls OR (95 % CI) P value
E2/E2 9(6.0) 1(0.6) 9.51(1.19,76.04) 0.03
E2/E3 35(23.3) 21(14.0) 1.87(1.03,3.40) 0.04
E2/E4 4(2.7) 7(4.7) 0.56(0.16,1.95) 0.36
E3/E3 76(50.7) 80(53.3) 0.90(0.57,1.41) 0.64
E3/E4 25(16.7) 31(20.7) 0.77(0.43,1.38) 0.38
E4/E4 1(0.6) 10(6.7) 0.09(0.01,0.74) 0.03
Liu et al. BMC Neurology  (2016) 16:14 Page 3 of 6
with multiple sclerosis risk [35]. Evidence from a meta-
analysis included 29 studies suggested that APOE E4 al-
lele was associated with an increased risk of developing
cerebral infarction in Chinese population [36].
The exact molecular mechanism of the association be-
tween APOE polymorphism and the risk of intracranial
aneurysms remains relatively unclear. APOE plays a crit-
ical role in redistributing lipids among central nervous
system cells for normal lipid homeostasis [37, 38],
repairing injured neurons [39], maintaining synaptoden-
dritic connections [40], neurite outgrowth [41], synaptic
plasticity [42], mitochondrial resistance to oxidative
stress [43], and glucose use by neurons and glial cells
[44, 45]. A case-control study in Russia found that intra-
cranial aneurysms with hypertension were associated
with the e2 allele and the e2/e3 APOE genotype [13].
This was consistent with our study.
There are some limitations to the present study that
should be mentioned. First of all, although this study
suggested that APOE polymorphism was associated with
intracranial aneurysms, more biological background data
are needed to explain our results. The current finding
might involve gene-to-environment interactions, which
were not explored in the present study. Second, the sam-
ple size of this study is relatively small, which may not
have enough statistical power to explore the real associ-
ation. Third, this is a hospital based case control study
and selection bias cannot be avoided and therefore the
subjects may not be representative of the general popu-
lation within China. Finally, these results should be
interpreted with caution because the population was
only from China, which reduces the possibility of con-
founding from ethnicity, however does not permit ex-
trapolation of the results to other ethnic groups.
Conclusions
In conclusion, our study suggested that APOE polymorph-
ism might be associated with intracranial aneurysms in
Chinese population. Additional studies are needed to con-
firm this finding.
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